Table 2. The association of commonest side effects of Pfizer vaccine (first dose) with age, gender, and comorbidities .
*p-value significant as <0.05
Variable | Fever | Pain at the injection site | |||||
Yes, n(%) | No, n(%) | p-value | Yes, n(%) | No, n(%) | p-value | ||
Age group | <30 years | 176(88.0%) | 124(62.0%) | <0.001* | 76(38.0%) | 124(62.0%) | <0.001* |
31-50 years | 297(56.6%) | 196(37.3%) | 329(62.7%) | 196(37.3%) | |||
>50 years | 227(82.5%) | 48(17.5%) | 227(82.5%) | 48(17.5%) | |||
Gender | Male | 400(62.1%) | 244(37.0%) | <0.001* | 380(59.0%) | 264(41.0%) | <0.001* |
Female | 300(84.3%) | 56(15.7%) | 252(70.8%) | 104(29.2%) | |||
Hypertension | Present | 180(64.3%) | 100(35.7%) | 0.017* | 208(74.3%) | 72(25.7%) | <0.001* |
Absent | 520(72.2%) | 200(27.8%) | 424(58.9%) | 296(41.1%) | |||
Diabetes mellitus | Present | 232(65.2%) | 124(34.8%) | 0.016* | 260(73.0%) | 96(27.0%) | <0.001* |
Absent | 468(72.7%) | 176(27.3%) | 372(57.8%) | 272(42.2%) |